Literature DB >> 15761872

p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area.

Mohammad Muzaffar Mir1, Nazir Ahmad Dar, Sailesh Gochhait, Showkat Ali Zargar, Abdul Gani Ahangar, R N K Bamezai.   

Abstract

Esophageal squamous cell carcinoma (ESCC) has been reported to show geographical variation in its incidence, even within areas of ethnic homogeneity. Kashmir valley, in north of India, has been described as a high-risk area for ESCC. Here, we make a preliminary attempt to study mutations in exons 5-8 (the DNA binding domain) of the tumor suppressor gene, p53, in 55 ESCC patients from Kashmir. Polymerase chain reaction followed by direct sequencing analysis revealed the presence of mutations in 36.36% (20/55) tumors, assessed for the extent of allelic instability. The 20 mutations, found in 20 patients, comprised of 17 single-base substitutions (11 transitions + 6 transversions) and 3 deletions. The 17 single-base variations represented 12 missense mutations, 2 nonsense mutations and 3 variations located in intron 6, 1 of which resulted in a splicing variant. The patients when compared for the incidence of p53 mutation with various demographic features revealed females to be at increased risk (p = 0.016; OR = 4.13; 95% CI = 1.26-13.46). Comparison of mutation profile with other high-risk areas reflected both differences and similarities indicating coexposure to a unique set of risk factors. This might be due to the special dietary and cultural practices of Kashmir that needs validation, as does the gender-based difference in the incidence of p53 mutation observed in this study. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15761872     DOI: 10.1002/ijc.21002

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients.

Authors:  Muhammad U Rashid; Sidra Gull; Kashif Asghar; Noor Muhammad; Asim Amin; Ute Hamann
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

2.  A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley.

Authors:  Imtiyaz Murtaza; Dhuha Mushtaq; Mushtaq A Margoob; Amit Dutt; Nisar Ahmad Wani; Ishfaq Ahmad; Mohan Lal Bhat
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

3.  Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma.

Authors:  Xiao-Fang Liu; Hao Zhang; Shi-Guang Zhu; Xian-Ting Zhou; Hai-Long Su; Zheng Xu; Shao-Jun Li
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

4.  Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma.

Authors:  Jing Gao; Zhengzhi Zou; Jing Gao; Haifang Zhang; Zhicai Lin; Yaya Zhang; Xianyang Luo; Changhua Liu; Jingdun Xie; Chengfu Cai
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 5.  Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir.

Authors:  Aga Syed Sameer
Journal:  Tumour Biol       Date:  2013-02-17

6.  Whole-exome sequencing of familial esophageal squamous cell carcinoma identified rare pathogenic variants in new predisposition genes.

Authors:  F F Golyan; T E Druley; M R Abbaszadegan
Journal:  Clin Transl Oncol       Date:  2019-07-18       Impact factor: 3.405

7.  Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area.

Authors:  Irfana Salam; Showket Hussain; Mohammad Muzaffar Mir; Nazir Ahmad Dar; Safiya Abdullah; Mushtaq Ahmad Siddiqi; Riyaz Ahmad Lone; Showkat Ahmad Zargar; Shashi Sharma; Suresh Hedau; Seemi Farhat Basir; Alok Chandra Bharti; Bhudev C Das
Journal:  Mol Cell Biochem       Date:  2009-06-10       Impact factor: 3.396

8.  SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene.

Authors:  A Syed Sameer; Nissar A Chowdri; Nidda Syeed; Mujeeb Z Banday; Zaffar A Shah; Mushtaq A Siddiqi
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

9.  Immunohistochemical Analysis of P53 and PRB in Esophageal Squamous Cell Carcinoma.

Authors:  Biswajit Dey; Vandana Raphael; Yookarin Khonglah; Kyrshanlang Giri Lynrah
Journal:  J Clin Diagn Res       Date:  2014-05-15

10.  KRAS and TP53 mutations in colorectal carcinoma.

Authors:  Khawla S Al-Kuraya
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.